The Emerging Roles of π Subunit-Containing GABA_A Receptors in Different Cancers

Area of Science:

• Oncology
• Neuroscience
• Molecular Biology

Background:

• Cancer remains a leading global cause of death, characterized by heterogeneity and late-stage detection, limiting effective treatments.
• There is a critical need for novel diagnostic tools and pharmaceutical targets to improve cancer patient outcomes.
• π-subunit-containing gamma-aminobutyric acid type A receptors are a class of targets with atypical properties and limited research, despite their discovery over 20 years ago.

Purpose of the Study:

• To review the elevated expression of π-subunit-containing gamma-aminobutyric acid type A receptors in specific cancer types.
• To explore the physiological functions of these receptors in healthy individuals.
• To examine the pro-tumorigenic effects of these receptors in ovarian, breast, gastric, cervical, and pancreatic cancers.

Main Methods:

• Literature review of existing studies on π-subunit-containing gamma-aminobutyric acid type A receptors.
• Analysis of research highlighting receptor expression levels in various cancer tissues.
• Synthesis of data on the physiological roles and oncogenic functions of these receptors.

Main Results:

• π-subunit-containing gamma-aminobutyric acid type A receptors exhibit higher expression in ovarian, breast, gastric, cervical, and pancreatic cancers.
• These receptors are expressed in several non-neuronal tissues, including the female reproductive system.
• Evidence suggests a pro-tumorigenic role for these receptors in the studied cancer types.

Conclusions:

• π-subunit-containing gamma-aminobutyric acid type A receptors represent promising candidates for novel cancer diagnostics and therapeutics.
• Further research is warranted to fully elucidate their function and therapeutic potential in oncology.
• Targeting these receptors could offer new avenues for combating various forms of cancer.